South Korea Invossa Incident Raises Suspicions About Regulators, Sponsor At Local Forum

Controversy over Kolon Life Science’s gene therapy Invossa continue to escalate with participants in a recent forum led by the country’s progressive political party raising suspicions over the company and drug authorities; they called for a re-examination of the current drug approval and development process and halt on further easing of regulations.